Intellia Therapeutics Stock Price Patterns
| NTLA Stock | USD 12.48 0.26 2.13% |
Momentum 56
Buy Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.95) | EPS Estimate Current Year (4.00) | EPS Estimate Next Year (3.60) | Wall Street Target Price 23.8571 | EPS Estimate Current Quarter (0.98) |
Using Intellia Therapeutics hype-based prediction, you can estimate the value of Intellia Therapeutics from the perspective of Intellia Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Intellia Therapeutics using Intellia Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Intellia using crowd psychology based on the activity and movement of Intellia Therapeutics' stock price.
Intellia Therapeutics Short Interest
A significant increase or decrease in Intellia Therapeutics' short interest from the previous month could be a good indicator of investor sentiment towards Intellia. Short interest can provide insight into the potential direction of Intellia Therapeutics stock and how bullish or bearish investors feel about the market overall.
200 Day MA 11.9903 | Short Percent 0.4389 | Short Ratio 6.96 | Shares Short Prior Month 42.6 M | 50 Day MA 11.0652 |
Intellia Therapeutics Hype to Price Pattern
Investor biases related to Intellia Therapeutics' public news can be used to forecast risks associated with an investment in Intellia. The trend in average sentiment can be used to explain how an investor holding Intellia can time the market purely based on public headlines and social activities around Intellia Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Intellia Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Intellia Therapeutics.
Intellia Therapeutics Implied Volatility | 1.53 |
Intellia Therapeutics' implied volatility exposes the market's sentiment of Intellia Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Intellia Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Intellia Therapeutics stock will not fluctuate a lot when Intellia Therapeutics' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Intellia Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Intellia because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Intellia Therapeutics after-hype prediction price | USD 12.66 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Intellia contract
Based on the Rule 16, the options market is currently suggesting that Intellia Therapeutics will have an average daily up or down price movement of about 0.0956% per day over the life of the 2026-04-17 option contract. With Intellia Therapeutics trading at USD 12.48, that is roughly USD 0.0119 . If you think that the market is fully incorporating Intellia Therapeutics' daily price movement you should consider acquiring Intellia Therapeutics options at the current volatility level of 1.53%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Intellia Therapeutics Basic Forecasting Models to cross-verify your projections. Intellia Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Intellia Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Intellia Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Intellia Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Intellia Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Intellia Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Intellia Therapeutics' historical news coverage. Intellia Therapeutics' after-hype downside and upside margins for the prediction period are 7.86 and 17.46, respectively. We have considered Intellia Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Intellia Therapeutics is somewhat reliable at this time. Analysis and calculation of next after-hype price of Intellia Therapeutics is based on 3 months time horizon.
Intellia Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Intellia Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Intellia Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Intellia Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.87 | 4.80 | 0.03 | 0.24 | 5 Events / Month | 6 Events / Month | In about 5 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
12.48 | 12.66 | 0.24 |
|
Intellia Therapeutics Hype Timeline
Intellia Therapeutics is now traded for 12.48. The entity has historical hype elasticity of 0.03, and average elasticity to hype of competition of 0.24. Intellia is expected to increase in value after the next headline, with the price projected to jump to 12.66 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 0.24%, whereas the daily expected return is now at 0.87%. The volatility of related hype on Intellia Therapeutics is about 1758.24%, with the expected price after the next announcement by competition of 12.72. The company reported the previous year's revenue of 57.88 M. Net Loss for the year was (519.02 M) with loss before overhead, payroll, taxes, and interest of (352.35 M). Given the investment horizon of 90 days the next expected press release will be in about 5 days. Check out Intellia Therapeutics Basic Forecasting Models to cross-verify your projections.Intellia Therapeutics Related Hype Analysis
Having access to credible news sources related to Intellia Therapeutics' direct competition is more important than ever and may enhance your ability to predict Intellia Therapeutics' future price movements. Getting to know how Intellia Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Intellia Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ZBIO | Zenas BioPharma Common | (0.05) | 10 per month | 11.65 | 0.01 | 12.20 | (11.66) | 68.95 | |
| PHVS | Pharvaris BV | 0.16 | 7 per month | 3.52 | 0.04 | 6.54 | (6.01) | 27.81 | |
| UPB | Upstream Bio | (1.52) | 8 per month | 0.00 | (0.14) | 7.84 | (12.87) | 57.85 | |
| SYRE | Spyre Therapeutics | 0.31 | 7 per month | 2.53 | 0.18 | 7.15 | (4.47) | 20.03 | |
| BHVN | Biohaven Pharmaceutical Holding | 0.75 | 11 per month | 3.56 | 0.1 | 10.23 | (6.69) | 29.39 | |
| ZYME | Zymeworks Common Stock | 0.76 | 8 per month | 2.62 | 0.06 | 4.46 | (4.49) | 36.09 | |
| IMNM | Immunome | 2.24 | 9 per month | 4.03 | 0.11 | 7.47 | (6.10) | 31.45 | |
| BCRX | BioCryst Pharmaceuticals | 0.07 | 23 per month | 0.00 | (0.03) | 4.43 | (4.19) | 16.75 | |
| STOK | Stoke Therapeutics | 0.44 | 9 per month | 3.07 | 0.09 | 7.31 | (5.30) | 22.52 | |
| WVE | Wave Life Sciences | (0.43) | 7 per month | 3.74 | 0.09 | 6.72 | (5.96) | 164.47 |
Intellia Therapeutics Additional Predictive Modules
Most predictive techniques to examine Intellia price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Intellia using various technical indicators. When you analyze Intellia charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Intellia Therapeutics Predictive Indicators
The successful prediction of Intellia Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Intellia Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Intellia Therapeutics based on analysis of Intellia Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Intellia Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Intellia Therapeutics's related companies. | 2023 | 2024 | 2025 | 2026 (projected) | Days Sales Outstanding | 366.82 | 53.71 | 48.34 | 76.97 | PTB Ratio | 2.58 | 1.32 | 1.52 | 1.44 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Complementary Tools for Intellia Stock analysis
When running Intellia Therapeutics' price analysis, check to measure Intellia Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intellia Therapeutics is operating at the current time. Most of Intellia Therapeutics' value examination focuses on studying past and present price action to predict the probability of Intellia Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intellia Therapeutics' price. Additionally, you may evaluate how the addition of Intellia Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |